The arginine methyltransferase PRMT2 binds RB and regulates E2F function. 2006

Takanobu Yoshimoto, and Manfred Boehm, and Michelle Olive, and Martin F Crook, and Hong San, and Thomas Langenickel, and Elizabeth G Nabel
Cardiovascular Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, 31 Center Dr., 31/5A48, Bethesda, MD 20892, USA.

The retinoblastoma gene product (RB) is an important regulator of E2F activity. RB recruits a number of proteins, including HDACs, SWI/SNF complex, lysine methyl transferase (SUV39H1) and DNA methyltransferase (DNMT1), all of which negatively regulate E2F activity with RB. Here, we show that RB interacts with PRMT2, a member of the protein arginine methyltransferase family, to regulate E2F activity. PRMT2 directly bound and interacted with RB through its AdoMet binding domain, in contrast to other PRMT proteins, including PRMT1, PRMT3 and PRMT4. In reporter assays, PRMT2 repressed E2F1 transcriptional activity in an RB-dependent manner. PRMT2 formed a ternary complex with E2F1 in the presence of RB. To further explore the role of endogenous PRMT2 in the regulation of E2F activity, the PRMT2 gene was ablated in mice by gene targeting. Compared with PRMT2(+/+) mouse embryonic fibroblasts (MEFs), PRMT2(-/-) MEFs demonstrated increased E2F activity and early S phase entry following release of serum starvation. Vascular injury to PRMT2(-/-) arteries results in a hyperplastic response, consistent with increased G1-S phase progression. Taken together, these findings demonstrate a novel mechanism for the regulation of E2F activity by a member of the protein arginine methyltransferase family.

UI MeSH Term Description Entries
D008780 Methyltransferases A subclass of enzymes of the transferase class that catalyze the transfer of a methyl group from one compound to another. (Dorland, 28th ed) EC 2.1.1. Methyltransferase
D011484 Protein-Arginine N-Methyltransferases Enzymes that catalyze the methylation of arginine residues of proteins to yield N-mono- and N,N-dimethylarginine. This enzyme is found in many organs, primarily brain and spleen. Protein Arginine Methyltransferase,Protein Methylase I,Protein Methyltransferase I,Protein-Arginine N-Methyltransferase,(Myelin Basic Protein)-Arginine N-Methyltransferase,Arginine Methylase,Myelin Basic Protein (Arginine) Methyltransferase,Type I Protein Arginine Methyltransferase,Type I Protein Arginine N-Methyltransferase,Type II Protein Arginine Methyltransferase,Arginine Methyltransferase, Protein,Methyltransferase, Protein Arginine,Protein Arginine N Methyltransferase,Protein Arginine N Methyltransferases,Type I Protein Arginine N Methyltransferase
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015533 Transcriptional Activation Processes that stimulate the GENETIC TRANSCRIPTION of a gene or set of genes. Gene Activation,Genetic Induction,Transactivation,Induction, Genetic,Trans-Activation, Genetic,Transcription Activation,Activation, Gene,Activation, Transcription,Activation, Transcriptional,Genetic Trans-Activation,Trans Activation, Genetic
D016160 Retinoblastoma Protein Product of the retinoblastoma tumor suppressor gene. It is a nuclear phosphoprotein hypothesized to normally act as an inhibitor of cell proliferation. Rb protein is absent in retinoblastoma cell lines. It also has been shown to form complexes with the adenovirus E1A protein, the SV40 T antigen, and the human papilloma virus E7 protein. Rb Protein,Retinoblastoma Nuclear Phosphoprotein p105-Rb,p105-Rb Protein,Rb Gene Product,Rb1 Gene Product,Retinoblastoma Nuclear Phosphoprotein p105 Rb,p105 Rb Protein

Related Publications

Takanobu Yoshimoto, and Manfred Boehm, and Michelle Olive, and Martin F Crook, and Hong San, and Thomas Langenickel, and Elizabeth G Nabel
November 2021, Life (Basel, Switzerland),
Takanobu Yoshimoto, and Manfred Boehm, and Michelle Olive, and Martin F Crook, and Hong San, and Thomas Langenickel, and Elizabeth G Nabel
June 1999, Oncogene,
Takanobu Yoshimoto, and Manfred Boehm, and Michelle Olive, and Martin F Crook, and Hong San, and Thomas Langenickel, and Elizabeth G Nabel
January 2011, Molecular and cellular biology,
Takanobu Yoshimoto, and Manfred Boehm, and Michelle Olive, and Martin F Crook, and Hong San, and Thomas Langenickel, and Elizabeth G Nabel
October 2007, The Journal of steroid biochemistry and molecular biology,
Takanobu Yoshimoto, and Manfred Boehm, and Michelle Olive, and Martin F Crook, and Hong San, and Thomas Langenickel, and Elizabeth G Nabel
August 2010, Developmental cell,
Takanobu Yoshimoto, and Manfred Boehm, and Michelle Olive, and Martin F Crook, and Hong San, and Thomas Langenickel, and Elizabeth G Nabel
December 2002, Current opinion in cell biology,
Takanobu Yoshimoto, and Manfred Boehm, and Michelle Olive, and Martin F Crook, and Hong San, and Thomas Langenickel, and Elizabeth G Nabel
April 2001, Human molecular genetics,
Takanobu Yoshimoto, and Manfred Boehm, and Michelle Olive, and Martin F Crook, and Hong San, and Thomas Langenickel, and Elizabeth G Nabel
February 2020, Cancer gene therapy,
Takanobu Yoshimoto, and Manfred Boehm, and Michelle Olive, and Martin F Crook, and Hong San, and Thomas Langenickel, and Elizabeth G Nabel
May 2007, Oncogene,
Takanobu Yoshimoto, and Manfred Boehm, and Michelle Olive, and Martin F Crook, and Hong San, and Thomas Langenickel, and Elizabeth G Nabel
September 2009, BMC developmental biology,
Copied contents to your clipboard!